SMV reorganizes upper management

Nuclear medicine vendor SMV has revamped its executive lineup,a move that has resulted in the departure of Colin McNaught, chairmanand CEO of the vendor's SMV America unit in Twinsburg OH, andAndre Debionne, chairman and CEO of the holding company for SMVAmerica and SMV International.

SMV spokesperson Robert Ripley said that Debionne's positionwas a transitional one designed to help smooth the integrationof SMV's predecessors, Sopha and Summit Nuclear, while McNaughtdeparted for personal reasons. McNaught previously was head ofSopha's U.S. unit.

Neither McNaught nor Debionne will be replaced, according toRipley. SMV International chief executive Jean Plazenet will assumethe responsibilities of both executives. Summit veteran RandallSommerdyke remains president of SMV America, Ripley said.